Access cutting-edge suicide risk treatment through this phase 2 clinical trial at a research site in The Bronx. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this The Bronx location
Preparing your pre-screening questions…
Access suicide risk specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related suicide risk treatment provided free
Check if you qualify for this suicide risk clinical trial in The Bronx, NY
No-Cost Study Care
Local to The Bronx
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this proof-of-concept clinical trial is to evaluate the initial safety, feasibility, and tolerability of the orexin mixed antagonist suvorexant in a sample of veteran adults with Major Depressive Disorder and elevated suicide risk. The main question it aims to answer is: Is Suvorexant safe, feasible, and tolerable for participants? Participants will: * Take Surovexant every day for four weeks (10mg in the first two weeks and 20mg in the second two weeks) * Visit the medical center at the beginning of the study (week 1), after taking Suvorexant for two weeks (week 3) and following the full Suvorexant dose (week 5) for in-person assessments. * Fill out self-report assessments (remotely) at week 2 (after one week of Suvorexant) and week 4 (after three weeks of Surovexant)
Sponsor: Marianne Goodman
Yes, this clinical trial (NCT06854224) has an active research site in The Bronx, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for suicide risk treatment options in The Bronx, NY, this clinical trial (NCT06854224) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our The Bronx research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced suicide risk specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all suicide risk clinical trials near you to find additional studies recruiting in your area.
See all interstitial cystitis clinical trials recruiting in The Bronx — not just this study.
Browse Interstitial Cystitis Trials in The Bronx →